Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**CYCS pseudogene 51 (CYCSP51)** is a full-length human pseudogene derived from the cytochrome c gene, also known as HCP1. It does not produce a functional protein but serves as an inactive genetic vestige resulting from retrotransposition events during evolution. There is no evidence it acts as a receptor, enzyme, transporter, or has a therapeutic function. This pseudogene is not considered a molecular target and does not participate in cellular signaling, biological pathways, or disease mechanisms[6][7]. Its identification is of evolutionary and genomic interest only. **Key information:** - CYCSP51 is classified strictly as a pseudogene in humans and has no active or actionable biological function[6][5][7]. - The label "HCP1" here refers to human cytochrome c pseudogene 1 and should not be confused with Hcp1 from bacterial Type VI Secretion System studies[1][3], which is a protein with structural and immunological relevance in bacterial pathogenesis. **Notable clarification:** - There is no evidence CYCSP51/HCP1 is a molecular target (drug, receptor, enzyme, etc.) in humans. - If the intent is to describe the bacterial Hcp1 protein relevant to secretion systems, that is a completely different molecule and context[1][3]. - CYCSP51 does not meet criteria for inclusion as a receptor, enzyme, transporter, or any other conventional therapeutic target; it is only a pseudogene.
None (not a target for therapeutic intervention; does not possess an actionable mechanism)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c, somatic pseudogene 51 (CYCSP51).